Your browser doesn't support javascript.
Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses.
Zhou, Runhong; To, Kelvin Kai-Wang; Peng, Qiaoli; Chan, Jacky Man-Chun; Huang, Haode; Yang, Dawei; Lam, Bosco Hoi-Shiu; Chuang, Vivien Wai-Man; Cai, Jian-Piao; Liu, Na; Au, Ka-Kit; Tsang, Owen Tak-Yin; Yuen, Kwok-Yung; Chen, Zhiwei.
  • Zhou R; AIDS Institute, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • To KK; Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Peng Q; Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Chan JM; State Key Laboratory for Emerging Infectious Diseases, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Huang H; Centre for Virology, Vaccinology and Therapeutics Limited, University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
  • Yang D; Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Lam BH; AIDS Institute, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Chuang VW; Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Cai JP; National Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, People's Republic of China.
  • Liu N; Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Au KK; AIDS Institute, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Tsang OT; AIDS Institute, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Yuen KY; Department of Pathology, Princess Margaret Hospital, Princess Margaret Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Chen Z; Quality & Safety Division, Hospital Authority, Hong Kong Special Administrative Region, People's Republic of China.
Clin Transl Med ; 12(1): e720, 2022 01.
Article in English | MEDLINE | ID: covidwho-1653216
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines / Variants Limits: Adult / Female / Humans / Male Language: English Journal: Clin Transl Med Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines / Variants Limits: Adult / Female / Humans / Male Language: English Journal: Clin Transl Med Year: 2022 Document Type: Article